SI-BONE (2K3) Stock Overview
A medical device company, focuses on solving musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
2K3 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
SI-BONE, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$16.90 |
| 52 Week High | US$17.90 |
| 52 Week Low | US$10.60 |
| Beta | 0.70 |
| 1 Month Change | 0% |
| 3 Month Change | 28.03% |
| 1 Year Change | n/a |
| 3 Year Change | 44.44% |
| 5 Year Change | -28.99% |
| Change since IPO | 0.96% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2K3 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 0% | -7.2% | -0.6% |
| 1Y | n/a | -19.8% | 9.9% |
Return vs Industry: Insufficient data to determine how 2K3 performed against the German Medical Equipment industry.
Return vs Market: Insufficient data to determine how 2K3 performed against the German Market.
Price Volatility
| 2K3 volatility | |
|---|---|
| 2K3 Average Weekly Movement | 6.5% |
| Medical Equipment Industry Average Movement | 6.1% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in DE Market | 12.9% |
| 10% least volatile stocks in DE Market | 2.6% |
Stable Share Price: 2K3 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 2K3's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 349 | Laura Francis | si-bone.com |
SI-BONE, Inc., a medical device company, focuses on solving musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. The company offers proprietary minimally invasive surgical implant systems to address sacroiliac joint dysfunction and degeneration, adult deformity and degeneration, and pelvic trauma, as well as implantable bone products. It also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with a proprietary 3D-printed porous surface and fenestrated design; iFuse TORQ, a line of 3D-printed threaded implants designed for applications in pelvic trauma and sacroliliac fusion; and iFuse Bedrock Granite Implant System that provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion; and iFuse TORQ TNT to treat pelvic trauma and sacroiliac joint dysfunction, as well as iFuse INTRA implants that are marketed as human cells, tissues, and cellular or tissue-based products.
SI-BONE, Inc. Fundamentals Summary
| 2K3 fundamental statistics | |
|---|---|
| Market cap | €614.45m |
| Earnings (TTM) | -€18.34m |
| Revenue (TTM) | €163.17m |
Is 2K3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2K3 income statement (TTM) | |
|---|---|
| Revenue | US$193.58m |
| Cost of Revenue | US$39.45m |
| Gross Profit | US$154.13m |
| Other Expenses | US$175.88m |
| Earnings | -US$21.75m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.50 |
| Gross Margin | 79.62% |
| Net Profit Margin | -11.24% |
| Debt/Equity Ratio | 20.6% |
How did 2K3 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/01/26 22:07 |
| End of Day Share Price | 2026/01/12 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
SI-BONE, Inc. is covered by 17 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Travis Steed | BofA Global Research |
| Craig Bijou | BofA Global Research |
| Travis Steed | BofA Global Research |